FDA
-
-
-
-
-
-
-
GH Research PLC (GHRS) PT Raised to $34 at Guggenheim
-
-
-
-
-
-
-
TD Cowen on GH Research PLC (GHRS): 'Today's update...was very cleane'
-
-
-
-
-
-
-
GH Research to Announce IND Status for GH001
-
-
-
-
-
-
-
GH Research reports 73% remission rate in depression trial data
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on GH Research PLC (GHRS)
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on GH Research PLC (GHRS)
-
-
-
-
-
-
-
GH Research Reports Full Year 2023 Financial Results and Provides Business Updates
-
322,084 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

